These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 17581625)

  • 1. A compass that points to lupus: genetic studies on type I interferon pathway.
    Kyogoku C; Tsuchiya N
    Genes Immun; 2007 Sep; 8(6):445-55. PubMed ID: 17581625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus erythematosus: all roads lead to type I interferons.
    Pascual V; Farkas L; Banchereau J
    Curr Opin Immunol; 2006 Dec; 18(6):676-82. PubMed ID: 17011763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetics and biology of Irf5-mediated signaling in lupus.
    Kozyrev SV; Alarcon-Riquelme ME
    Autoimmunity; 2007 Dec; 40(8):591-601. PubMed ID: 18075793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
    Banchereau J; Pascual V
    Immunity; 2006 Sep; 25(3):383-92. PubMed ID: 16979570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus.
    Means TK; Luster AD
    Ann N Y Acad Sci; 2005 Dec; 1062():242-51. PubMed ID: 16461805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
    Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
    Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.
    Graham RR; Kozyrev SV; Baechler EC; Reddy MV; Plenge RM; Bauer JW; Ortmann WA; Koeuth T; González Escribano MF; ; Pons-Estel B; Petri M; Daly M; Gregersen PK; Martín J; Altshuler D; Behrens TW; Alarcón-Riquelme ME
    Nat Genet; 2006 May; 38(5):550-5. PubMed ID: 16642019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
    Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
    Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
    Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.
    Lood C; Gullstrand B; Truedsson L; Olin AI; Alm GV; Rönnblom L; Sturfelt G; Eloranta ML; Bengtsson AA
    Arthritis Rheum; 2009 Oct; 60(10):3081-90. PubMed ID: 19790049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.
    Lövgren T; Eloranta ML; Båve U; Alm GV; Rönnblom L
    Arthritis Rheum; 2004 Jun; 50(6):1861-72. PubMed ID: 15188363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I interferon and lupus.
    Rönnblom L; Alm GV; Eloranta ML
    Curr Opin Rheumatol; 2009 Sep; 21(5):471-7. PubMed ID: 19525849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE).
    Demirci FY; Manzi S; Ramsey-Goldman R; Minster RL; Kenney M; Shaw PS; Dunlop-Thomas CM; Kao AH; Rhew E; Bontempo F; Kammerer C; Kamboh MI
    Ann Hum Genet; 2007 May; 71(Pt 3):308-11. PubMed ID: 17166181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus.
    Hellquist A; Järvinen TM; Koskenmies S; Zucchelli M; Orsmark-Pietras C; Berglind L; Panelius J; Hasan T; Julkunen H; D'Amato M; Saarialho-Kere U; Kere J
    J Rheumatol; 2009 Aug; 36(8):1631-8. PubMed ID: 19567624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lupus-like disease and high interferon levels corresponding to trisomy of the type I interferon cluster on chromosome 9p.
    Zhuang H; Kosboth M; Lee P; Rice A; Driscoll DJ; Zori R; Narain S; Lyons R; Satoh M; Sobel E; Reeves WH
    Arthritis Rheum; 2006 May; 54(5):1573-9. PubMed ID: 16645992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRF5-mediated signaling and implications for SLE.
    Lazzari E; Jefferies CA
    Clin Immunol; 2014 Aug; 153(2):343-52. PubMed ID: 24928322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins, inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, function as inhibitors of cellular and molecular components involved in type I interferon production.
    Amuro H; Ito T; Miyamoto R; Sugimoto H; Torii Y; Son Y; Nakamichi N; Yamazaki C; Hoshino K; Kaisho T; Ozaki Y; Inaba M; Amakawa R; Fukuhara S
    Arthritis Rheum; 2010 Jul; 62(7):2073-85. PubMed ID: 20506142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus.
    Wenzel J; Zahn S; Bieber T; Tüting T
    Arch Dermatol Res; 2009 Jan; 301(1):83-6. PubMed ID: 18784932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
    Kozyrev SV; Lewén S; Reddy PM; Pons-Estel B; ; Witte T; ; Junker P; Laustrup H; Gutiérrez C; Suárez A; Francisca González-Escribano M; Martín J; ; Alarcón-Riquelme ME
    Arthritis Rheum; 2007 Apr; 56(4):1234-41. PubMed ID: 17393452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.